Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 02 - 08 source : Www.biospace.com save search
Cerus Corporation to Release Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022
Published: 2022-02-08 (Crawled : 20:00) - biospace.com/
CERS | $1.63 -2.98% -3.07% 750K
|
Health Technology
|
| O: -0.19%
H: 3.45%
C: 3.45%
financial results corporation results
PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2021 Financial Results
Published: 2022-02-08 (Crawled : 20:00) - biospace.com/
PTCT | News | $25.19 -0.4% -0.4% 670K
|
Health Technology
|
| O: -0.37%
H: 2.63%
C: 1.51%
financial results conference therapeutics results
Palisade Bio (Nasdaq: PALI) to Announce Adhesions Clinical Data at SAGES 2022 Annual Meeting
Published: 2022-02-08 (Crawled : 19:00) - biospace.com/
PALI | $6.54 10.29% 9.33% 1.6M
|
Manufacturing
|
| O: 2.08%
H: 10.2%
C: 6.12%
nasdaq
Eyenovia Concludes Type A Meeting with FDA Related to MydCombi™ NDA Resubmission No additional clinical work required; NDA resubmission anticipated in Q3 2022
Published: 2022-02-08 (Crawled : 19:00) - biospace.com/
EYEN | $0.5349 -3.34% -3.46% 720K
|
Health Technology
|
| O: 0.68%
H: 7.05%
C: 3.69%
fda eye work submission mydcombi resubmission
Gain Therapeutics Presents Preclinical Data on its Structurally Targeted Allosteric Regulators in GBA1 Gaucher Disease
Published: 2022-02-08 (Crawled : 19:00) - biospace.com/
GANX | $3.14 -0.63% -0.64% 81K
|
Professional, Scientific, and T...
|
| O: -0.54%
H: 2.09%
C: -6.3%
therapeutics disease preclinical pre-clinical
FDA Approves JUVÉDERM® VOLBELLA® XC For Undereye Hollows
Published: 2022-02-08 (Crawled : 19:00) - biospace.com/
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
derm fda eye
Soligenix to Present at the 2022 BIO CEO & Investor Conference
Published: 2022-02-08 (Crawled : 19:00) - biospace.com/
SNGX | $0.4963 5.15% -7.27% 4.2M
|
Health Technology
|
| O: 0.78%
H: 0.79%
C: -2.24%
ceo conference
Ocuphire Completes Enrollment in MIRA-3 Pivotal Phase 3 Clinical Trial for Nyxol® in RM and Announces Two Upcoming Medical Conference Presentations
Published: 2022-02-08 (Crawled : 19:00) - biospace.com/
OCUP | $1.745 0.29% 0.29% 92K
|
Health Technology
|
| O: -0.34%
H: 8.47%
C: 8.47%
nyxol trial conference presentation phase 3 enroll
Akero Therapeutics Completes Enrollment of Phase 2b HARMONY Study in Pre-Cirrhotic NASH Patients
Published: 2022-02-08 (Crawled : 19:00) - biospace.com/
AKRO | $21.62 -0.78% -0.79% 820K
|
Health Technology
|
| O: 0.11%
H: 1.01%
C: 0.37%
phase 2 phase 2b therapeutics nash enroll
Healx and Ovid Therapeutics to Enter Strategic Partnership
Published: 2022-02-08 (Crawled : 19:00) - biospace.com/
OVID | $3.12 -1.58% -1.6% 160K
|
Health Technology
|
| O: 1.37%
H: 2.2%
C: 1.69%
partnership therapeutics
Alkermes Announces Positive Topline Results From ENLIGHTEN-Early Phase 3b Study of LYBALVI® in Patients Early in Illness
Published: 2022-02-08 (Crawled : 18:00) - biospace.com/
ALKS | News | $24.05 1.18% 1.16% 2.3M
|
Health Technology
|
| O: -0.21%
H: 1.36%
C: -1.49%
lybalvi topline results positive topline phase 3
Rockley Photonics Announces Bioptx™ Biomarker Sensing Platform for Professional Healthcare, Including First-of-its-Kind Non-Invasive, Continuous Biosensing Wristband
Published: 2022-02-08 (Crawled : 18:00) - biospace.com/
RKLY | $0.1924 0.0% 0
|
|
| O: 0.0%
H: 20.45%
C: 18.75%
health thc photo platform biomarkers
Immunome’s Antibody Cocktail Effective Against SARS-CoV-2 Omicron Variant in In Vitro Live Virus Testing
Published: 2022-02-08 (Crawled : 18:00) - biospace.com/
IMNM | $17.43 -5.27% -5.57% 950K
|
Health Technology
|
| O: 7.1%
H: 2.76%
C: -10.94%
sars-cov-2 test antibody in vitro
Medtronic to announce financial results for its third quarter of fiscal year 2022
Published: 2022-02-08 (Crawled : 17:00) - biospace.com/
MDT | News | $79.08 -0.22% 0.0% 5.5M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
financial results results
MyMD Pharmaceuticals Announces Positive Clinical Data in Advance of Upcoming Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
Published: 2022-02-08 (Crawled : 17:00) - biospace.com/
MYMD | $2.1 0.0% 45K
|
Manufacturing
|
| O: 0.23%
H: 1.16%
C: -5.35%
health phase 2 als trial positive
Gilead to Present Latest Antiviral Research and Development Data at CROI 2022 Addressing Urgent Global Needs
Published: 2022-02-08 (Crawled : 17:00) - biospace.com/
GILD | $66.94 -0.55% -0.55% 5.3M
|
Health Technology
|
| O: -0.27%
H: 0.81%
C: -0.2%
research test antiviral
Simulations Plus to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Published: 2022-02-08 (Crawled : 17:00) - biospace.com/
SLP | News | $44.82 -1.19% -1.2% 82K
|
Technology Services
|
| O: -1.21%
H: 2.81%
C: 2.01%
diagnostic health conference life science
Satsuma Pharmaceuticals to Present at the Virtual 11th Annual SVB Leerink Global Healthcare Conference
Published: 2022-02-08 (Crawled : 17:00) - biospace.com/
STSA | $1.1 -0.9% -0.91% 0
|
Health Technology
|
| O: -8.0%
H: 9.73%
C: 6.83%
health als thc conference svb leerink global
Changing Lives, Delivering Value: Quoin Pharmaceuticals is Making the Balancing Act Look Easy
Published: 2022-02-08 (Crawled : 15:30) - biospace.com/
QNRX | $0.703 -2.36% -2.42% 37K
|
Professional, Scientific, and T...
|
| O: -1.41%
H: 2.52%
C: 1.43%
als liver
Kiora Pharmaceuticals Announces Participation at 2022 BIO CEO & Investor Conference
Published: 2022-02-08 (Crawled : 15:30) - biospace.com/
KPRX | $0.519 -5.6% -5.93% 190K
|
Manufacturing
|
| O: 1.56%
H: 4.26%
C: -0.97%
als ces ceo conference
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.